Quantitation of biperiden in whole blood by MALDI-QTOF tandem mass spectrometry, and estimation of new metabolites in urine of deceased subjects treated with biperiden antemortem
In this work, the application of matrix-assisted laser desorption ionization (MALDI)-quadrupole time-of-flight (QTOF)-tandem mass spectrometry (MS/MS) to the quantitation of the anticholinergic/antiparkinson drug biperiden in human whole blood, and the estimation of new phase I metabolites of biperi...
Saved in:
Published in | Forensic toxicology Vol. 35; no. 1; pp. 86 - 93 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.01.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1860-8965 1860-8973 |
DOI | 10.1007/s11419-016-0341-x |
Cover
Summary: | In this work, the application of matrix-assisted laser desorption ionization (MALDI)-quadrupole time-of-flight (QTOF)-tandem mass spectrometry (MS/MS) to the quantitation of the anticholinergic/antiparkinson drug biperiden in human whole blood, and the estimation of new phase I metabolites of biperiden in human urine, were performed for the first time. The limit of detection of biperiden in human whole blood was 0.3 ng/mL with a quantitation range of 1–100 ng/mL using 20 μL each of whole blood. The developed method was successfully applied to the determination of biperiden in whole blood obtained from two deceased subjects having a history of biperiden treatment. The concentrations of biperiden in the whole blood samples were 1.7 and 17.5 ng/mL. The MALDI-QTOF-MS/MS method was also used to estimate the metabolites of biperiden in urine obtained from the subjects. Six new metabolites formed by hydroxylation and/or dehydration were detected. |
---|---|
ISSN: | 1860-8965 1860-8973 |
DOI: | 10.1007/s11419-016-0341-x |